EC Number   |
Title |
Organism |
|---|
   3.4.11.18 | Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
| 3.4.11.18 | Identification of the molecular basis of inhibitor selectivity between the human and streptococcal type I methionine aminopeptidases |
Streptococcus pneumoniae |
| 3.4.11.18 | Identification of the molecular basis of inhibitor selectivity between the human and streptococcal type I methionine aminopeptidases |
Homo sapiens |
| 3.4.11.18 | Identification of the molecular basis of inhibitor selectivity between the human and streptococcal type I methionine aminopeptidases |
Streptococcus pneumoniae CGSP14 |
| 3.4.11.18 | MapB protein is the essential methionine aminopeptidase in Mycobacterium tuberculosis |
Mycobacterium tuberculosis variant bovis |
| 3.4.11.18 | Methionine aminopeptidase 2 is a key regulator of apoptotic like cell death in Leishmania donovani |
Leishmania donovani |
| 3.4.11.18 | Methionine aminopeptidase 2 is a key regulator of apoptotic like cell death in Leishmania donovani |
Leishmania donovani BPK282A1 |
| 3.4.11.18 | Molecular and biochemical characterization of methionine aminopeptidase of Babesia bovis as a potent drug target |
Babesia bovis |
| 3.4.11.18 | N-terminal acetylome analysis reveals the specificity of Naa50 (Nat5) and suggests a kinetic competition between N-terminal acetyltransferases and methionine aminopeptidases |
Homo sapiens |
| 3.4.11.18 | N-Terminal methionine processing by the zinc-activated Plasmodium falciparum methionine aminopeptidase 1b |
Plasmodium falciparum |
